JAMP SODIUM POLYSTYRENE SULFONATE
Google image searchProduct monograph
Active ingredient
sodium polystyrene sulfonate, 1 G/G
DIN: 02497557
Dosage form(s): POWDER FOR SUSPENSION
Route(s) of administration: ORAL, RECTAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 04-FEB-2021
ATC:
- V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
- V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
- V03AE — Drugs for treatment of hyperkalemia and hyperphosphatemia (ATC, ATC/DDD)
- V03AE01 — POLYSTYRENE SULPHONATE (ATC/DDD)
Reference brand drug: Kayexalate
Pharmaceutical standard: MFR
